S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study

[摘要]

[发布日期] [发布机构]

[效力级别] [学科分类] 肿瘤学

[关键词] [时效性]

浏览次数：2

统一登录查看全文激活码登录查看全文